Utility of choline positron emission tomography/computed tomography for lymph node involvement identification in intermediate- to high-risk prostate cancer: a systematic literature review and meta-analysis.
about
Molecular Imaging of Prostate CancerPositron emission tomography (PET) in primary prostate cancer staging and risk assessmentComparative performance of PET tracers in biochemical recurrence of prostate cancer: a critical analysis of literature.Positron Emission Tomography (PET) in OncologyFocal salvage therapy for local prostate cancer recurrences after primary radiotherapy: a comprehensive reviewIntegration of (68)Ga-PSMA-PET imaging in planning of primary definitive radiotherapy in prostate cancer: a retrospective study.Molecular imaging of urogenital diseases.Molecular and functional imaging for detection of lymph node metastases in prostate cancer.Lymphotropic nanoparticle-enhanced MRI in prostate cancer: value and therapeutic potential.Diagnostic performance of PET/CT with tracers other than F-18-FDG in oncology: an evidence-based review.Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis.Imaging biomarkers in prostate cancer: role of PET/CT and MRI.Synergistic action of image-guided radiotherapy and androgen deprivation therapy.Imaging of prostate cancer with PET/CT using (18)F-Fluorocholine.Initial prostate cancer diagnosis and disease staging--the role of choline-PET-CT.Ultra-small superparamagnetic iron oxides for metastatic lymph node detection: back on the block.Current use of PSMA-PET in prostate cancer management.New frontiers in prostate cancer imaging: clinical utility of prostate-specific membrane antigen positron emission tomography.A urologist's perspective on prostate cancer imaging: past, present, and future.The very-high-risk prostate cancer: a contemporary update.PSMA PET and Radionuclide Therapy in Prostate Cancer.PET and PET/CT with radiolabeled choline in prostate cancer: a critical reappraisal of 20 years of clinical studies.Advances in Imaging in Prostate and Bladder Cancer.Value of 111 In-prostate-specific membrane antigen (PSMA)-radioguided surgery for salvage lymphadenectomy in recurrent prostate cancer: correlation with histopathology and clinical follow-up.Influence of (11)C-choline PET/CT on radiotherapy planning in prostate cancer.Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [(18)F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate canc[Focus on molecular imaging in prostate cancer].Elective pelvic versus prostate bed-only salvage radiotherapy following radical prostatectomy: A propensity score-matched analysis.A Comparative Study of 68Gallium-Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography and Magnetic Resonance Imaging for Lymph Node Staging in High Risk Prostate Cancer Patients: An Initial Experience.Comparison of Prostate-Specific Membrane Antigen-Based 18F-DCFBC PET/CT to Conventional Imaging Modalities for Detection of Hormone-Naïve and Castration-Resistant Metastatic Prostate Cancer.PSMA-Based [(18)F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer.[Potential of PET/MRI for diagnosis of prostate cancer].¹⁸F-fluorocholine PET/CT compared with extended pelvic lymph node dissection in high-risk prostate cancer.Is there still a role for computed tomography and bone scintigraphy in prostate cancer staging? An analysis from the EUREKA-1 database.Salvage Low Dose Rate Brachytherapy For Recurrent Prostate Cancer After External Beam Radiotherapy: Results From A Single Institution With Focus On Toxicity And Functional Outcomes.Lymph node imaging in initial staging of prostate cancer: An overview and update.Current status of theranostics in prostate cancer.Preoperative multiparametric MRI of the prostate for the prediction of lymph node metastases in prostate cancer patients treated with extended pelvic lymph node dissection.Functional and Targeted Lymph Node Imaging in Prostate Cancer: Current Status and Future Challenges.Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer.
P2860
Q33620520-F0D77ACD-5CC4-47FC-BBC0-023A59D853BCQ33890153-B268FCD2-0EBB-40A8-9AF5-BAC26C389C30Q34228828-71046735-646F-4E4A-B83B-CE52F0FDA559Q34774840-3F521651-1F7F-4CB7-86F9-8C0086DAA4EEQ35969717-F2D84308-F822-4CE1-87FF-9050CC492CE8Q36942136-C6601489-6909-4D28-BB19-883B559D6C05Q37550399-9348BBC5-4DA1-48FB-8A33-C4E05BE23A0FQ38119113-B38C0231-EBC6-4E34-AC81-05DBF5508E32Q38178849-99C922AB-C5ED-42D3-BD8F-CA60116B0BC7Q38197532-21FE8853-E533-44A4-8D22-B50FB6D15011Q38212848-C1D17380-5041-4841-BB0B-5EC85E584B88Q38321182-0EA2A53E-F1D3-4A73-A042-D37D29B45C48Q38387844-8026E0A2-B8E1-4B94-B6B2-44D67C6D7F87Q38479113-39140040-FFA3-477F-9BA3-0D3CF83ECB62Q38564109-D7174464-2E51-4419-918D-E75133420A1DQ38734277-58AEF2D1-7258-4150-8017-412909D7F990Q38744524-35465D3C-29BC-46F1-9A4C-0E1E7A9109F7Q38757513-8322766E-71E2-4AC0-B9A8-65E53423861EQ38823661-D7E9BD5F-BFA0-4A4C-B2AD-ECCF64A49CB9Q38952181-3504B252-AC33-4360-AF21-8833F5E18689Q39003089-E1681179-735C-488F-BEB1-47A4A637D88FQ39242140-E7B0083D-C0A3-4B86-96D8-F4868FD558E9Q39441078-596C9ACA-3092-4EBD-BE5C-1457C29DB51BQ40468376-F8A54065-F858-4BCF-97A0-3842DD3A12E1Q41094016-5931A2E8-AB9F-4C73-944A-C21EA412CD49Q41482900-427EFA95-BBA3-45DA-8D1F-B802A7034489Q41585395-9535EAE9-804F-4EF8-9D55-87E2D81F7B59Q41599603-68240F0E-C10A-402A-AEF2-1596981495E4Q41826244-ACEC77CE-159C-45DA-89D0-E411B293E046Q42060482-6155248C-0D68-48A9-9921-59C948182FCAQ42328242-C3929881-C395-48A8-98C9-5240EDDE028AQ43636204-E1215BD9-65B5-4E02-9623-8DE9EA98B4ABQ46558981-A549E076-4BD2-499E-AB29-97E7781FD8B0Q46696128-6F1FC7AE-3D57-4E04-AA07-23C3AFE90596Q47099465-7346B0A9-84B0-4218-9F8B-87FDABC302E3Q47157403-50186403-564F-4A26-B088-362AE8EC5387Q47241139-A5F7DA40-641D-410F-ACDE-0FEAD4EDCB3FQ47261973-C332750C-3251-4D46-A320-E06FD9D999FFQ47829959-DF667F03-D2E3-4F2C-88B9-1E2D28D1556CQ48227663-BD3173DD-D75E-4BED-A45C-73430957A85B
P2860
Utility of choline positron emission tomography/computed tomography for lymph node involvement identification in intermediate- to high-risk prostate cancer: a systematic literature review and meta-analysis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Utility of choline positron em ...... ture review and meta-analysis.
@en
type
label
Utility of choline positron em ...... ture review and meta-analysis.
@en
prefLabel
Utility of choline positron em ...... ture review and meta-analysis.
@en
P2093
P1433
P1476
Utility of choline positron em ...... ature review and meta-analysis
@en
P2093
Fabio Zattoni
Filiberto Zattoni
Pier Carlo Muzzio
P304
P356
10.1016/J.EURURO.2012.09.039
P407
P577
2012-09-25T00:00:00Z